TransCode Therapeutics, Inc. (RNAZ)
NASDAQ: RNAZ · Real-Time Price · USD
3.880
-0.080 (-2.02%)
At close: Aug 10, 2026, 4:00 PM EDT
3.990
+0.110 (2.84%)
After-hours: Aug 10, 2026, 7:34 PM EDT
TransCode Therapeutics Market Cap
TransCode Therapeutics has a market cap or net worth of $3.69 million as of August 10, 2026. Its market cap has decreased by -57.43% in one year.
Market Cap
3.69M
Enterprise Value
-9.15M
1-Year Change
-57.43%
Ranking
Category
Stock Price
$3.88
ChartMarket Cap Chart
Since the IPO on July 9, 2021, TransCode Therapeutics's market cap has decreased from $47.87M to $3.69M, a decrease of -92.30%. That is a compound annual growth rate of -39.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 3.69M | -41.13% |
| Dec 31, 2025 | 6.26M | 166.92% |
| Dec 31, 2024 | 2.35M | -43.27% |
| Dec 29, 2023 | 4.14M | -51.10% |
| Dec 30, 2022 | 8.46M | -73.50% |
| Dec 31, 2021 | 31.92M | -33.32% |
| Jul 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.50M |
| Mustang Bio | 4.47M |
| Creative Medical Technology Holdings | 4.44M |
| Revelation Biosciences | 4.42M |
| PMGC Holdings | 4.18M |
| Silo Pharma | 4.10M |
| Galmed Pharmaceuticals | 3.91M |
| HCW Biologics | 3.90M |